Intraocular and systemic levels of vascular endothelial growth factor in advanced cases of retinopathy of prematurity
Authors:
- Raul Velez-MontoyaRVRaul Velez-Montoya
- Fromow- GuerraFGFromow- Guerra
- Guerrero- NaranjoGNGuerrero- Naranjo
- Carmen ClappCCCarmen Clapp
- Morales- CantonMCMorales- Canton
- Quiros- MercadoQMQuiros- Mercado
- Jose Carlos RiveraJRJose Carlos Rivera
- Garcia- AguirreGAGarcia- Aguirre
Open Access
- 1 August 2010
- journal article
- research article
- Published by Taylor & Francis in Clinical Ophthalmology
- Vol. 4, 947-953
Abstract
Purpose: To measure vitreous, aqueous, subretinal fluid and plasma levels of vascular endothelial growth factor in late stages of retinopathy of prematurity. Methods: Interventional study. We enrolled patients with clinical diagnoses of bilateral stage V retinopathy of prematurity, confirmed by b-scan ultrasound and programmed for vitrectomy. During surgery we took samples from blood, aqueous, vitreous, and subretinal fluids. The vascular endothelial growth factor concentration in each sample was measured by ELISA reaction. A control sample of aqueous, vitreous and blood was taken from patients with congenital cataract programmed for phacoemulsification. For statistical analysis, a Mann–Whitney and a Wilcoxon W test was done with a significant P value of 0.05. Results: We took samples of 16 consecutive patients who met the inclusion criteria. The vascular endothelial growth factor levels in the study group were: aqueous, 76.81 ± 61.89 pg/mL; vitreous, 118.53 ± 65.87 pg/mL; subretinal fluid, 1636.58 ± 356.47 pg/mL; and plasma, 74.64 ± 43.94 pg/mL. There was a statistical difference between the study and the control group (P < 0.001) in the aqueous and vitreous samples. Conclusion: Stage 5 retinopathy of prematurity has elevated intraocular levels of vascular endothelial growth factor, which remains high despite severe retinal lesion. There was no statistical difference in plasma levels of the molecule between the control and study group.Keywords
This publication has 38 references indexed in Scilit:
- Aqueous Humor and Plasma Levels of Vascular Endothelial Growth Factor and Nitric Oxide in Patients With Pseudoexfoliation Syndrome and Pseudoexfoliation GlaucomaJournal of Glaucoma, 2010
- Simultaneous Analyses of Vitreous Levels of 27 Cytokines in Eyes with Retinopathy of PrematurityOphthalmology, 2009
- IGF-I, VEGF y bFGF, como factores pronósticos de la aparición de la retinopatía de la prematuridadArchivos de la Sociedad Española de Oftalmología, 2006
- Retinopathy of Prematurity: Two Distinct Mechanisms That Underlie Zone 1 and Zone 2 DiseaseAmerican Journal of Ophthalmology, 2006
- The prevalence of retinopathy of prematurity in very low birth weight newborn infantsJornal de Pediatria, 2006
- Riluzole Inhibits VEGF-Induced Endothelial Cell Proliferation In Vitro and Hyperoxia-Induced Abnormal Vessel Formation In VivoInvestigative Ophthalmology & Visual Science, 2005
- Retinopathy of prematurityCurrent Opinion in Ophthalmology, 2003
- Gene transfer by viral vectors into blood vessels in a rat model of retinopathy of prematurityBritish Journal of Ophthalmology, 2001
- Vascular Endothelial Growth Factor and Hepatocyte Growth Factor Levels Are Differentially Elevated in Patients with Advanced Retinopathy of PrematurityThe American Journal of Pathology, 2000
- Glaucoma as a cause of poor vision in severe retinopathy of prematurityGraefe's Archive for Clinical and Experimental Ophthalmology, 1993